UK gov­ern­ment, pri­vate in­vestors dole out $340M+ to drug, di­ag­nos­tic man­u­fac­tur­ers

The gov­ern­ment of the Unit­ed King­dom is giv­ing out grants to sev­er­al man­u­fac­tur­ers that have a pres­ence in Eng­land, Wales and North­ern Ire­land.

The gov­ern­ment an­nounced that four com­pa­nies, in­clud­ing Ipsen, con­tract man­u­fac­tur­er Phar­maron, DNA man­u­fac­tur­er Touch­light and di­ag­nos­tic test pro­duc­er Ran­dox, will re­ceive a to­tal of £277 mil­lion ($341.1 mil­lion). Ac­cord­ing to a re­lease from the UK gov­ern­ment, this rep­re­sents the first por­tion of grants from the Life Sci­ences In­no­v­a­tive Man­u­fac­tur­ing Fund.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER